Soleno Therapeutics, Inc. (NASDAQ:SLNO) has achieved a major regulatory milestone as the European Medicines Agency (EMA) ...

Dexedrine (dextroamphetamine ) and Adderall (amphetamine) are both stimulant drugs approved to treat ADHD and narcolepsy. While they can help you focus, they can cause some unpleasant side effects ...

Detailed price information for Soleno Therapeutics Inc (SLNO-Q) from The Globe and Mail including charting and trades.

Obesity medications in development could improve accessibility and affordability, according to a presenter at Obesity ...

Adderall is used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. The effects can be positive when taken as intended but dangerous if you use it without medical supervision ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to U.S. patients. VYKAT XR is indicated for the treatment of hyperphagia in ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to U.S. patients. VYKAT XR is indicated for the treatment of hyperphagia ...

Google is also bringing Gemini to Android XR, its newest platform developed in collaboration with Samsung for headsets, glasses, and other extended reality devices. “When the first headset from ...

Joel LaMontagne is Founder and CEO of Trivver, a multi-patented Extended Reality and Artificial Intelligence (XR/AI) Ad Platform. As the founder of Trivver—with over 110 patents in extended ...